AMT-116 in Patients with Solid Tumors

NCT06782334 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: AMT-116

Sponsor

Multitude Therapeutics Inc.